HBLSX
Price
$15.10
Change
-$0.00 (-0.00%)
Updated
Sep 6 closing price
VWINX
Price
$26.14
Change
-$0.00 (-0.00%)
Updated
Sep 6 closing price
Ad is loading...

HBLSX vs VWINX

Header iconHBLSX vs VWINX Comparison
Open Charts HBLSX vs VWINXBanner chart's image
Hartford Balanced Income R4
Price$15.10
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Wellesley® Income I
Price$26.14
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
HBLSX vs VWINX Comparison Chart
Loading...
VS
HBLSX vs. VWINX commentary
Sep 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBLSX is a Sell and VWINX is a StrongSell.

FUNDAMENTALS
Fundamentals
VWINX has more cash in the bank: 51.5B vs. HBLSX (12.7B). VWINX (3.38) and HBLSX (3.25) have matching dividends . HBLSX was incepted earlier than VWINX: HBLSX (14 years) vs VWINX (54 years). HBLSX is a more actively managed with annual turnover of: 57.00 vs. VWINX (53.00). HBLSX has a lower initial minimum investment than VWINX: HBLSX (0) vs VWINX (3000). HBLSX annual gain was more profitable for investors over the last year : 13.60 vs. VWINX (10.44). HBLSX return over 5 years is better than : 17.28 vs. VWINX (7.29).
HBLSXVWINXHBLSX / VWINX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years54 years-
Gain YTD8.1227.227112%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets12.7B51.5B25%
Annual Yield % from dividends3.253.3896%
Returns for 1 year13.6010.44130%
Returns for 3 years-0.43-6.287%
Returns for 5 years17.287.29237%
Returns for 10 years37.9823.63161%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AVA38.540.91
+2.42%
Avista Corp
KIDS32.280.68
+2.15%
OrthoPediatrics Corp
DOC22.580.17
+0.76%
Healthpeak Properties
BRAG4.900.02
+0.41%
Bragg Gaming Group
ERNA1.50-0.03
-1.96%
Eterna Therapeutics